Page 189 - Programme book for The International Liver Congress 2015, EASL ILC 2015

P0400 MICRORNA SIGNATURE OF EARLY-STAGE ePOSTERS
P0401 HEPATOCELLULAR CARCINOMA ARISING IN HCV-
YI P0402 RELATED CIRRHOSIS
YI P0403 Giorgia Ghittoni, Letizia Veronese*, Francesca Torello Viera, Valeria Curti,
YI P0404 Michele Ghitti, Laura L. Rosa, Valentina Ravetta, Luisa Siciliani,
YI P0405 Sandro Rossi, Italy
YI P0406
THE SERINE PROTEASE FSAP (FACTOR VII ACTIVATING
PROTEASE) MAINTAINS THE DIFFERENTIATED STATE OF
MOUSE HEPATOCYTES
Adoracion Martinez-Palacian*, Sandip Kanse, Norway

COMBINATION THERAPY FOR HEPATOCELLULAR
CARCINOMA: A SYSTEMS BIOLOGY PERSPECTIVE ON
THE SYNERGISTIC ANTITUMOR ACTIVITY OF SORAFENIB
WITH PI3K/AKT PATHWAY INHIBITORS
Tulin Ersahin*, Nurcan Tuncbag, Aybar Acar, Rengul Cetin-Atalay,
Turkey

STEATOTIC LIVER AS A SOURCE OF HEPATIC
PROGENITOR CELLS WITH THERAPEUTIC POTENTIAL
Wei-Yu Lu*, Atsunori Tsuchiya, Luke Boulter, Rachel Guest,
Davina Wojtacha, Thomas Bird, Tak Yung Man, David Hay, John Iredale,
Stuart Forbes, The United Kingdom

CYCLIN E1 EXPRESSION LEVEL DETERMINE THE ANTI-
PROLIFERATIVE RESPONSE OF THE PHARMACOLOGICAL
CDK2 INHIBITOR ROSCOVITINE IN HEPATOMA CELLS AND
LIVER
Yulia A. Nevzorova*, Wei Hu, Nadine Hoeltke Hoeltke, Ute Haas,
Christian Trautwein, Christian Liedtke, Germany

MOLECULAR MECHANISMS UNDERLYING THE
UNPRECEDENTED LIVER REGENERATION INDUCED BY
ALPPS SURGERY
Magda Langiewicz*, Andrea Schlegel, Humar Bostjan, Rolf Graf, Pierre-
Alain Clavien, Switzerland

DELETION OF CDK1 IN THE LIVER INDUCES CHANGES IN
PYRUVATE METABOLISM
Matias Caldez*, Xing Qi Teo, Noemi Van Hul, Philip Lee, Philipp Kaldis,
Singapore

Vienna, Austria • April 22–26, 2015 189